Raymond James Reinstates Outperform on Qorvo, Announces $120 Price Target
Raymond James analyst Srini Pajjuri reinstates Qorvo (NASDAQ:QRVO) with a Outperform and announces $120 price target.
BMO Capital Maintains Market Perform on Qorvo, Raises Price Target to $105
BMO Capital analyst Ambrish Srivastava maintains Qorvo (NASDAQ:QRVO) with a Market Perform and raises the price target from $90 to $105.
Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch
With a full week of earnings behind us, it’s time to take stock of the fourth-quarter reporting season so far. Overall, the news flow has been mixed, although tech earnings have grossly disappointed.
Zomedica To Take Control Of Aspects Of TRUFORMA Product Line Previously Provided By Qorvo
Under the agreements, Zomedica will take control of aspects of the TRUFORMA product line previously provided by Qorvo, including development of new assays and manufacturing both instruments and assay cartridges. This
Wells Fargo Maintains Equal-Weight on Qorvo, Raises Price Target to $90
Wells Fargo analyst Gary Mobley maintains Qorvo (NASDAQ:QRVO) with a Equal-Weight and raises the price target from $80 to $90.
JP Morgan Downgrades Qorvo to Underweight, Lowers Price Target to $90
JP Morgan analyst Bill Peterson downgrades Qorvo (NASDAQ:QRVO) from Overweight to Underweight and lowers the price target from $125 to $90.
S&P 500, Nasdaq Futures Search For Direction As Key Fed Rate Decision Awaited Today — AMD, Qualcomm And These Stocks In Focus
Trading in the U.S. index futures suggests a mixed start on Wednesday, although the Fed rate decision and the signals coming out from the central bank will ultimately decide which direction the market would take.
Barclays Downgrades Qorvo to Equal-Weight, Lowers Price Target to $90
Barclays analyst Blayne Curtis downgrades Qorvo (NASDAQ:QRVO) from Overweight to Equal-Weight and lowers the price target from $120 to $90.